After the outbreak of SARS-CoV-2, nucleic acid testing quickly entered people’s lives. In addition to the polymerase chain reaction (PCR) which was commonly used in nucleic acid testing, isothermal amplification methods were also important nucleic acid testing methods. Among several common isothermal amplification methods like displaced amplification, rolling circle amplification, and so on, recombinase polymerase amplification (RPA) was recently paid more attention to. It had the advantages like a simple operation, fast amplification speed, and reaction at 37-42°C, et al. So it was very suitable for field detection. However, there were still some disadvantages to RPA. Herein, our review mainly summarized the principle, advantages, and disadvantages of RPA. The specific applications of RPA in bacterial detection, fungi detection, virus detection, parasite detection, drug resistance gene detection, genetically modified food detection, and SARS-CoV-2 detection were also described. It was hoped that the latest research progress on RPA could be better delivered to the readers who were interested in RPA.
8 March 2024 in Frontiers in Bioengineering and Biotechnology
Introduction:Salmonella was one of the most common bacteria that caused foodborne illness, with S. typhimurium (Salmonella typhimurium) and S. enteritidis (Salmonella enteritidis) infections accounting for more than 75% of human salmonella infections.Methods: In this study, we developed a method of dual recombinase polymerase amplification (RPA) combined with a lateral flow dipstick for the rapid detection of S. typhimurium and S. enteritidis in clinical specimens (stool).Results: The entire reaction process, including amplification and result reading, could be completed within 65 min. The detection limits of S. typhimurium and S. enteritidis in pure culture samples were 5.23 × 101 CFU/mL and 3.59 × 101 CFU/mL, respectively. The detection limits of S. typhimurium and S. enteritidis in artificially contaminated samples were 8.30 × 101 CFU/mL and 2.70 × 102 CFU/mL, respectively. In addition, the method had no cross-reaction with other pathogenic microorganisms. The results in clinical samples were fully consistent with those obtained using Bacterial Analysis Manual, with sensitivity and specificity were 100% (8/8) and 100% (17/17) for S. typhimurium and 100% (4/4) and 100% (21/21) for S. enteritidis, respectively.Discussion: The detection limits of S. typhimurium and S. enteritidis in artificially contaminated samples were higher than those in pure culture samples, which might be attributed to the inherent complex composition of artificially contaminated samples. In addition, the detection limits of S. typhimurium and S. enteritidis in the same sample were also different, which might be attributed to different amplification efficiency of two target genes in the same reaction system.Conclusion: This assay had potential application outdoors, as it could be performed within 1 h at 38°C without a complex instrument, and the results could be observed with the naked eye. In conclusion, the dual RPA-LFD assay established in this study had practical significance for the rapid detection of S. typhimurium and S. enteritidis in the future.
27 June 2024 in Frontiers in Cellular and Infection Microbiology
The bacterium Klebsiella pneumoniae (Kp) was the primary pathogen of hospital-acquired infection, but the current detection method could not rapidly and conveniently identify Kp. Recombinase polymerase amplification (RPA) was a fast and convenient isothermal amplification technology, and the clustered regularly interspaced short palindromic repeats (CRISPR) system could rapidly amplify the signal of RPA and improve its limit of detection (LOD). In this study, we designed three pairs of RPA primers for the rcsA gene of Kp, amplified the RPA signal through single-strand DNA reporter cleavage by CRISPR/Cas12a, and finally analyzed the cleavage signal using fluorescence detection (FD) and lateral flow test strips (LFTS). Our results indicated that the RPA-CRISPR/Cas12a platform could specifically identify Kp from eleven common clinical pathogens. The LOD of FD and LFTS were 1 fg/μL and 10 fg/μL, respectively. In clinical sample testing, the RPA-CRISPR/Cas12a platform was consistent with the culture method and qPCR method, and its sensitivity and specificity were 100% (16/16) and 100% (9/9), respectively. With the advantages of detection speed, simplicity, and accuracy, the RPA-CRISPR/Cas12a platform was expected to be a convenient tool for the early clinical detection of Kp.
Pseudomonas aeruginosa (PA), an opportunistic pathogen commonly responsible for hospital-acquired infections, poses significant threats to human health. To enable rapid and reliable PA detection while effectively mitigating aerosol contamination risks inherent in conventional methods. We developed a glycerol one-pot Recombinase-aided Amplification (RAA)/CRISPR-Cas12a method. Four result reading methods were established: Fluorescence Detection (FD), Blue Light Irradiation Detection (BLD), and Ultraviolet Irradiation Detection (UID), as well as Lateral Flow Chromatography Strip (LFS). The glycerol one-pot RAA-CRISPR/Cas12a method demonstrated high specificity and sensitivity in detecting the PA-specific lasB gene. The detection limit reached 1.20 × 10-4 ng/μL (fluorescence-based) and 1.20 × 10−3 ng/μL (LFS-based). In validation against 64 clinical isolates, compared to conventional PCR, the assay achieved 100% sensitivity, specificity, and accuracy in lasB detection. In conclusion, the glycerol one-pot RAA/CRISPR-Cas12a method provides a rapid, sensitive, and straightforward platform, providing a promising approach for clinical diagnosis of PA and environmental surveillance applications.
Escherichia coli and Klebsiella pneumoniae are major hospital-acquired pathogens, posing severe threats to critically ill and immunocompromised patients. Their pathogenicity and virulence factors easily cause invasive infections, endangering patient health and life. This study developed a dual recombinase polymerase amplification combined with Clustered Regularly Interspaced Short Palindromic Repeats-Cas12a assay for rapid, simultaneous, specific detection of E. coli uidA and K. pneumoniae rcsA genes. The assay operated at 37°C, and the total reaction time was approximately 70 min. The analytical sensitivity for E. coli and K. pneumoniae was 5.37 × 10¹ copies/μL and 5.90 × 10¹ copies/μL, respectively. It showed excellent specificity (no cross-reactivity) and 100% concordance with PCR results in clinical sample validation. This assay overcame limitations of traditional methods, such as bacterial culture (time-consuming) and PCR (the dependency on expensive thermal cyclers), and offers advantages of rapidity, high sensitivity, simplicity, and cost-effectiveness, providing a powerful tool for rapid, accurate clinical diagnosis of E. coli and K. pneumoniae infections. IMPORTANCE: Escherichia coli and Klebsiella pneumoniae are the main pathogens causing hospital-acquired infections, which can lead to serious complications and pose a significant challenge to public health. Therefore, establishing rapid, sensitive, specific, and reliable detection methods for E. coli and K. pneumoniae is of great significance for promoting accurate early clinical diagnosis and guiding treatment decisions. With the increasing incidence of mixed infections, single-target nucleic acid testing can no longer meet clinical needs. In this study, the efficient recombinase polymerase amplification (RPA) isothermal amplification technique was combined with the highly sensitive Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Cas12a detection system to successfully develop a duplex RPA-CRISPR-Cas12a method. This system can specifically and simultaneously identify E. coli (targeting the uidA gene) and K. pneumoniae (targeting the rcsA gene) in a single detection process.